share_log

Theravance Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Irenic Capital Management LP(5.5%),Irenic Capital Evergreen Master Fund LP(5.5%), etc.

Theravance Biopharma | SC 13G:超過5%持股股東披露文件-Irenic Capital Management LP(5.5%),Irenic Capital Evergreen Master Fund LP(5.5%)等

SEC announcement ·  02/14 16:04
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息